Nkarta announces november & december 2020 investor conference schedule

South san francisco, calif., nov. 05, 2020 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a clinical-stage biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

NKTX Ratings Summary

NKTX Quant Ranking